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Growing teratoma syndrome (GTS) was first described
by Logothetis et al [1] and is characterized by an en-
larged neoplastic mass of nonseminomatous germ cell
tumors (NSGCTs) following chemotherapy, with nor-
malization of previously elevated serum tumor markers
and absence of any NSGCT components. The inci-
dence of GTS in metastatic NSGCTs of the testis is
estimated to be around 1.9–7.6% [1,2], while GTS is
less common in ovarian NSGCT. Tonkin et al [3]
reported the first ovarian case of GTS in 1991. To
date, only a few case reports of ovarian GTS have been
documented in the medical literature [4], and no case
reports of Asian women have been published. Fur-
thermore, the use of three-dimensional (3D) ultrasound
for the diagnosis and management of ovarian GTS has
not been reported. We present the case of a 29-year-
old Asian woman with a primary diagnosis of immature
teratoma and GTS. We used 3D ultrasound and com-
puted tomography (CT) for diagnosis and follow-up in
this patient.
A previously healthy, 29-year-old Taiwanese woman
was referred to a local clinic with abdominal discom-
fort and a palpable abdominal mass in January 2006.
An exploratory laparotomy and left salpingo-oophorec-
tomy were performed. Histopathologic examination of
the pelvic mass (about 21 × 21 × 13 cm) revealed an
immature teratoma grade I. Microscopically, the tissue
sections had the appearance of an immature teratoma,
composed of abundant mature tissues including skin
and respiratory type epithelium, intermixed with some
slightly immature cartilage and loose stroma. Focal
areas of neural tissue with no obvious mitotic activity
were also seen.
After surgery, she was transferred to our medical
center for adjuvant therapy because of the detection 
of a progressively elevated serum α-fetoprotein (AFP)
level (1,839 ng/mL). Pelvic two-dimensional sonogra-
phy disclosed a right adnexal mass (3.5 × 5 cm) with
suspicious recurrent disease. CT scan revealed a lower-
density pelvic mass with an ill-defined irregular shape
near to the uterus (Figure 1).
Chemotherapy with cisplatin, etoposide and
bleomycin (PEB) were promptly administered because
of the suspicion of malignancy. After three cycles of PEB
chemotherapy, the AFP level normalized (6.16 ng/mL).
However, after completion of the chemotherapy, pelvic
two-dimensional sonography revealed a progressively
enlarged heteroechogenic tumor mass (6.3 × 5.3 cm)
in the cul-de-sac, even though her serum tumor mark-
ers, including AFP, CA-125, CA-199, carcinoembryonic
antigen, squamous cell carcinoma antigen and human
chorionic gonadotropin, remained normal. Notably,
3D sonography depicted the pelvic mass, which was
characterized by an echogenic mass, scattered ane-
choic areas, punctate calcification, and smooth margins
over the three axes (Figure 2). In addition, 3D power
Doppler and 3D color Doppler sonography showed no
flow over or within the mass. After chemotherapy, a
CT scan of the abdomen revealed an enhanced nodule
(about 1.5 cm) over the segment VI surface of the liver,
and a well-circumscribed, irregularly shaped soft-tissue
mass (about 8 cm in size) with streak-like calcifica-
tions and heterogeneous enhancement occupying the
cul-de-sac (Figure 3). Scanty ascites and para-aortic
lymph node enlargement were also seen.
The patient underwent a second intentional laparo-
tomy to investigate these findings. In order to preserve
fertility, partial omentectomy, retroperitoneal lymph node
dissection and complete resection of the multiple solid
masses over the cul-de-sac, omentum and peritoneal
cavity were undertaken. Histopathologic examination of
sections of the masses showed only mature teratoma
consisting of normal skin elements, respiratory tract
GROWING TERATOMA SYNDROME: AN ASIAN
WOMAN WITH IMMATURE TERATOMA OF LEFT
OVARY AFTER CHEMOTHERAPY
Tsung-Ying Hsieh, Ya-Min Cheng*, Fong-Ming Chang, Chen-Yang Chou
Department of Obstetrics and Gynecology, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan.
*Correspondence to: Dr Ya-Min Cheng, Department
of Obstetrics and Gynecology, National Cheng
Kung University Medical College and Hospital,
138, Victory Road, Tainan 70428, Taiwan.
E-mail: chengym@mail.ncku.edu.tw
Accepted: December 17, 2007
Taiwan J Obstet Gynecol • June 2009 • Vol 48 • No 2 187
Growing Teratoma Syndrome
A B
Figure 1. Contrast-enhanced axial pelvic computed tomography scans of the lower pelvis, (A) 295 mm below benchmark,
and (B) 300 mm below benchmark. Both were obtained after initial surgery with elevated α-fetoprotein, demonstrating a 




Figure 2. Three-dimensional orthogonal sonography of the growing teratoma syndrome tumors, obtained after completion
of six cycles of the cisplatin, etoposide and bleomycin chemotherapy with normal α-fetoprotein. Three (A) X, (B) Y, and (C) Z
axial images disclosed punctate calcifications (black arrows), scattered anechoic holes (white arrows), and smooth margins
in all three axis.
mucosa, more mature cartilage, bone, glial tissue with
degenerative astrocytes, ganglion cells, fat tissue, and
occasional retinal-like structures. No evidence of imma-
ture tissue or malignant components could be found
in any of the sections. The lymph nodes were normal.
The patient received no further treatment at follow-
up, and all the tumor markers remained within normal
limits. No signs of recurrence had appeared at the time
of this report, 6 months after the second debulking
operation for GTS.
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Although GTS was first described by Logothetis et al
[1] in 1982, DiSaia et al [5] had described a similar
phenomenon 5 years earlier, which they called “chemo-
therapeutic retroconversion”. It is now thought that
GTS and chemotherapeutic retroconversion are differ-
ent names representing the same disease entity [6]. The
underlying mechanism of GTS, however, is not clearly
understood. Elimination of the malignant components
of NSGCT after chemotherapy is a possible mechanism
responsible for this pathology. This chemotherapeutic
retroconversion phenomenon of GTS means that clini-
cians often misinterpret it as a chemoresistant tumor
or recurrent malignancy because of its radiologic or
clinical presentation as a growing or persistent mass.
Complete resection is the standard treatment for mature
teratomas because of the risk of malignant transfor-
mation and of organ damage, owing to their uncertain
growth rate.
Female ovarian GTS is extremely rare, and no reports
of ovarian GTS in Asian women have been described.
No racial differences in female GTS have been men-
tioned in the literature, and the reason for this lack of
reports is unknown. Further international collabora-
tive studies are warranted.
To our knowledge, no 3D sonographic features of
GTS have previously been reported. In this study, we
describe the 3D sonography findings, including a scat-
tered anechoic area and miliary punctate calcifications
which may represent mature components of fatty tis-
sue and bony tissue, respectively. Furthermore, clear and
smooth margins were noted on all three axes. To our
knowledge, this is the first case illustrating the GTS
characteristics of multiple anechoic areas and calcifi-
cations using 3D ultrasound.
No peripheral or penetrating flow over the mass was
detected by 3D color Doppler or 3D power Doppler
scanning. Combining these findings of 3D sonogra-
phy, color Doppler and power Doppler indicated the
development of a mature teratoma without neovas-
cularization, a sign of malignancy. However, we could
not exclude the possibility of a recurrence of NSGCT,
especially when an obviously growing tumor was
observed. From the follow-up of this case, 3D sonog-
raphy was no less sensitive than CT for differential
diagnosis, especially when combined with color flow
Doppler scanning. Furthermore, 3D sonography has
the advantages over CT of being convenient, safe, inex-
pensive, nonradioactive, and noninvasive. We, there-
fore, believe that 3D sonography could be a useful
diagnostic tool for GTS.
Although GTS has a good prognosis, close follow-up
with serial tumor marker measurements and imaging
studies are highly recommended, because stabilization
of GTS can take as long as 10 years after diagnosis.
Variable imaging findings and tumor marker results
may suggest the presence of a mature lesion, and 
surgical resection or biopsy is necessary to exclude
malignant recurrence. At the time of this report, nor-
malization of tumor markers and no evidence of recur-
rence had been observed in our patient. She was
disease-free 6 months after diagnosis, with preserved
fertility capacity.
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